Tiina Hervonen

Tiina Hervonen currently serves as the Business Unit Director for Rare Diseases, Plasma Derived Therapies, and Oncology at Takeda, a position held since September 2021. Hervonen has extensive experience in the pharmaceutical industry, having also held the title of Business Unit Director at Takeda Oncology since March 2018, alongside previous roles including Sales Manager, Brand Manager, and Disease Area Manager at Takeda. Prior experience includes serving as a Disease Area Manager and Brand & Sales Manager in oncology at Novartis, as well as various managerial roles at GlaxoSmithKline and Roche Pharmaceuticals. Hervonen is pursuing a degree as an HR specialist in Human Resources Management at The Finnish Institute for Enterprise Management, scheduled for completion in March 2024, and has completed executive education at Aalto University.